Please login to the form below

Not currently logged in
Email:
Password:

heart failure

This page shows the latest heart failure news and features for those working in and with pharma, biotech and healthcare.

Pfizer finalises $6.7bn acquisition of Arena Pharmaceuticals

Pfizer finalises $6.7bn acquisition of Arena Pharmaceuticals

Arena brings with it two development-stage cardiovascular assets – temanogrel for Raynaud's phenomenon secondary to systemic sclerosis and microvascular obstruction, and APD418 for acute heart failure.

Latest news

More from news
Approximately 49 fully matching, plus 265 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Cardiovascular disease: The scale of the challenge Cardiovascular disease: The scale of the challenge

    As part of efforts set out in NHS England’s Long Term Plan to prevent 150, 000 deaths over the next decade from the likes of heart attacks and strokes, the ... Thousands of cases of stroke, diabetes, heart failure and kidney disease could and should be

  • Claire wins Healthcare Communications Leader at Communiqué 2021 Claire wins Healthcare Communications Leader at Communiqué 2021

    Excellence in Patient Programmes for our work with Novartis.The Fighting Failure: Reprioritising Heart Failure Care in the UK campaign created practical resources for the heart failure (HF) community and a

  • Communiqué 2021 – in real life! Communiqué 2021 – in real life!

    Fighting Failure: Reprioritising Heart Failure Care in the UK with Novartis is a finalist in Excellence in Patient Programmes.The campaign created practical resources for the heart failure (HF) community and

  • Remote Patient Monitoring

    3. It can be especially helpful for patients who are managing a more complex self-care processes such as post-operative care, home dialysis, diabetes or congestive heart failure.

  • Nanobiotechnology, Artificial Intelligence, and Virtual Care

    Venk Varadan, Co-founder &CEO at Nanowear, explores the use of cloth-based nanosensor technology, AI, and deep-learning-enabled diagnostics for remote monitoring of congestive heart failure, chronic diseases, and

More from PMHub
Approximately 2 fully matching, plus 11 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...